Cirdan secures £7.5m from 57 Stars and the Investment Fund for Northern Ireland to scale delivery capabilities
The £7.5m financing comprises backing from 57 Stars and the Investment Fund for Northern Ireland.
Cirdan is a medical technology company based in Lisburn that provides software and imaging solutions to accelerate disease diagnosis. Its products are deployed in clinical laboratories across multiple continents.
Lisburn health tech firm Cirdan has secured £7.5m in funding from 57 Stars and the Investment Fund for Northern Ireland. The capital will be deployed to accelerate delivery capabilities, expand specialist teams, and enhance product offerings as the company targets further international expansion.
The financing comprises £5m from 57 Stars and £2.5m from the Investment Fund for Northern Ireland, marking the latter's largest equity investment to date. Cirdan currently operates across the UK, the US, and Australia, providing diagnostic software to over 200 clinical laboratories and hospitals globally.
From the founder
"The backing of 57 Stars and the Investment Fund for Northern Ireland is a testament to the value and potential of our technology."
Hugh Cormican
CEO at Cirdan
Investor perspective
"Cirdan is a shining example of the innovation and expertise that Northern Ireland has to offer."
Neil Simms
Investment Director, Investment Fund for Northern Ireland
Use of funds
- 01Continue product development
- 02Grow the team
- 03Expand into international markets
- 04Scale operations
